← FDA Drug Approvals (Drugs@FDA)
HEPARIN SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EMERGE BIOSCIENCE · Approved 2018-12-14
Drug application
- FDA Application #
ANDA211005- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- HEPARIN SODIUM
- Generic name
- HEPARIN SODIUM
- Active ingredients
- HEPARIN SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- EMERGE BIOSCIENCE
- Manufacturer
- NorthStar RxLLC
- First approval
- 2018-12-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown